Cargando…

Delving into vaccine hesitancy through multicentre studies: VAX-TRUST and INF-ACT projects’ insights

Vaccine hesitancy is a wide and varied phenomenon and represents a challenge for healthcare professionals (HCPs), who may encounter obstacles in building trusting relationships with parents and patients. Depicting the multifaceted aspects of hesitancy and finding effective tools that could help HCPs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Moro, G, Bert, F, Odone, A, De Vito, C, Carta, M, Langiano, E, Ferrara, M, Vuolanto, P, De Vito, E, Siliquini, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596823/
http://dx.doi.org/10.1093/eurpub/ckad160.014
_version_ 1785125195568119808
author Lo Moro, G
Bert, F
Odone, A
De Vito, C
Carta, M
Langiano, E
Ferrara, M
Vuolanto, P
De Vito, E
Siliquini, R
author_facet Lo Moro, G
Bert, F
Odone, A
De Vito, C
Carta, M
Langiano, E
Ferrara, M
Vuolanto, P
De Vito, E
Siliquini, R
author_sort Lo Moro, G
collection PubMed
description Vaccine hesitancy is a wide and varied phenomenon and represents a challenge for healthcare professionals (HCPs), who may encounter obstacles in building trusting relationships with parents and patients. Depicting the multifaceted aspects of hesitancy and finding effective tools that could help HCPs in addressing this issue are major public health priorities. This presentation will provide insights about two multicentre research initiatives that aim to respond to these needs. The “VAX-TRUST - Addressing Vaccine Hesitancy in Europe” project (funding from European Union's Horizon 2020 research and innovation program under Grant Agreement No. 965280) involves several institutions across Finland, Belgium, Poland, the Czech Republic, Italy, Portugal, and the UK. One of the goals of VAX-TRUST is to assist HCPs in dealing with hesitancy by implementing tailored interventions, specific for each target region. The process of development of interventions, starting from data supporting the planning up to the final intervention framework, will be discussed. The INF-ACT project (Next Generation EU funding within the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases, Project no. PE00000007) is a multicentre collaboration including universities and institutions throughout Italy. Within this project, the EPI-MOD node will contribute to realize novel monitoring methods to gather information on human behaviours during outbreaks and evaluate vaccine hesitancy levels and determinants. Among the main objectives, EPI-MOD will examine features and applications of immunization registries and will delve into vaccine hesitancy through a broad Italian nationwide survey, profiling subgroups of population at high risk for vaccine hesitancy. Overall, the results of these two large projects will allow to integrate novel data into information for action by identifying interventions that could be used to support HCPs and vulnerable groups that may require additional attention.
format Online
Article
Text
id pubmed-10596823
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105968232023-10-25 Delving into vaccine hesitancy through multicentre studies: VAX-TRUST and INF-ACT projects’ insights Lo Moro, G Bert, F Odone, A De Vito, C Carta, M Langiano, E Ferrara, M Vuolanto, P De Vito, E Siliquini, R Eur J Public Health Parallel Programme Vaccine hesitancy is a wide and varied phenomenon and represents a challenge for healthcare professionals (HCPs), who may encounter obstacles in building trusting relationships with parents and patients. Depicting the multifaceted aspects of hesitancy and finding effective tools that could help HCPs in addressing this issue are major public health priorities. This presentation will provide insights about two multicentre research initiatives that aim to respond to these needs. The “VAX-TRUST - Addressing Vaccine Hesitancy in Europe” project (funding from European Union's Horizon 2020 research and innovation program under Grant Agreement No. 965280) involves several institutions across Finland, Belgium, Poland, the Czech Republic, Italy, Portugal, and the UK. One of the goals of VAX-TRUST is to assist HCPs in dealing with hesitancy by implementing tailored interventions, specific for each target region. The process of development of interventions, starting from data supporting the planning up to the final intervention framework, will be discussed. The INF-ACT project (Next Generation EU funding within the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases, Project no. PE00000007) is a multicentre collaboration including universities and institutions throughout Italy. Within this project, the EPI-MOD node will contribute to realize novel monitoring methods to gather information on human behaviours during outbreaks and evaluate vaccine hesitancy levels and determinants. Among the main objectives, EPI-MOD will examine features and applications of immunization registries and will delve into vaccine hesitancy through a broad Italian nationwide survey, profiling subgroups of population at high risk for vaccine hesitancy. Overall, the results of these two large projects will allow to integrate novel data into information for action by identifying interventions that could be used to support HCPs and vulnerable groups that may require additional attention. Oxford University Press 2023-10-24 /pmc/articles/PMC10596823/ http://dx.doi.org/10.1093/eurpub/ckad160.014 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Parallel Programme
Lo Moro, G
Bert, F
Odone, A
De Vito, C
Carta, M
Langiano, E
Ferrara, M
Vuolanto, P
De Vito, E
Siliquini, R
Delving into vaccine hesitancy through multicentre studies: VAX-TRUST and INF-ACT projects’ insights
title Delving into vaccine hesitancy through multicentre studies: VAX-TRUST and INF-ACT projects’ insights
title_full Delving into vaccine hesitancy through multicentre studies: VAX-TRUST and INF-ACT projects’ insights
title_fullStr Delving into vaccine hesitancy through multicentre studies: VAX-TRUST and INF-ACT projects’ insights
title_full_unstemmed Delving into vaccine hesitancy through multicentre studies: VAX-TRUST and INF-ACT projects’ insights
title_short Delving into vaccine hesitancy through multicentre studies: VAX-TRUST and INF-ACT projects’ insights
title_sort delving into vaccine hesitancy through multicentre studies: vax-trust and inf-act projects’ insights
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596823/
http://dx.doi.org/10.1093/eurpub/ckad160.014
work_keys_str_mv AT lomorog delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT bertf delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT odonea delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT devitoc delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT cartam delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT langianoe delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT ferraram delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT vuolantop delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT devitoe delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights
AT siliquinir delvingintovaccinehesitancythroughmulticentrestudiesvaxtrustandinfactprojectsinsights